PREMIUM
World
Pfizer reports loss as Covid-19 revenues shrink
Pfizer said it is midway through a "cost realignment" program that will yield $3.5 billion in annual savings through 2024.
Pfizer said it is midway through a "cost realignment" program that will yield $3.5 billion in annual savings through 2024.
By: NewVision Reporter, Journalists @NewVision
________________
NEW YORK - Pfizer reported Tuesday a loss following a sharp fall in the sales of its Covid-19 vaccine and therapeutic from pandemic peaks.
The drugmaker